J Renal Inj Prev. 2017;6(1): 49-55. doi: 10.15171/jrip.2017.09
PMID: 28487872        PMCID: PMC5414519

Original Article

Incidence and severity of nausea and vomiting in a group of maintenance hemodialysis patients

Mohammad Reza Asgari 1, Fatemeh Asghari 1,2, Ali Asghar Ghods 1 * , Raheb Ghorbani 3, Nahid Hoshmand Motlagh 4, Fatemeh Rahaei 2

Cited by CrossRef: 13

1- Ho C, Martinusen D, Lo C. A Review of Cannabis in Chronic Kidney Disease Symptom Management. Can J Kidney Health Dis. 2019;6:205435811982839 [Crossref]
2- Hiß M. Von der Peritonealdialyse an die Hämodialyse – und zurück. Nephrologe. 2019;14(4):261 [Crossref]
3- Chu S, Ng W, Yeam C, Khan R, Low L, Quah J, Foo W, Seng J. Manipulative and body-based methods in chronic kidney disease patients: A systematic review of randomized controlled trials. Complementary Therapies in Clinical Practice. 2022;48:101593 [Crossref]
4- Naseri-Salahshour V, Sajadi M, Abedi A, Fournier A, Saeidi N. Reflexology as an adjunctive nursing intervention for management of nausea in hemodialysis patients: A randomized clinical trial. Complementary Therapies in Clinical Practice. 2019;36:29 [Crossref]
5- Gao J, Shi M, Jiang H, Zhu X, Wei L, Qin X. MicroRNA-339-5p inhibits lipopolysaccharide-induced rat mesangial cells by regulating the Syk/Ras/c-Fos pathway. Naunyn-Schmiedeberg's Arch Pharmacol. 2022;395(9):1075 [Crossref]
6- Biniaz V, Karimi Moonaghi H, Froutan R, Ebadi A. Hemodialysis Adequacy Sacrificed for Business: A Qualitative Study. Nephro-Urol Mon. 2018;10(3) [Crossref]
7- Matthews M, Carswell C, Redmond A, Bolton S, Murphy K, Mullan R, McAneney H, McKeaveney C, Noble H. A nonrandomised pilot study to examine the feasibility and acceptability of reflexology in patients undergoing hospital‐based haemodialysis (solitude study). J Ren Care. 2021;47(4):255 [Crossref]
8- Gholyaf M, Sheikh V, Yasrebifar F, Mohammadi Y, Mirjalili M, Mehrpooya M. Effect of mirtazapine on pruritus in patients on hemodialysis: a cross-over pilot study. Int Urol Nephrol. 2020;52(6):1155 [Crossref]
9- Heydarbaki M, Amerian M, Abbasi A, Amanpour F, Mohammadpourhodki R, Ebrahimi H. The effects of omega-3 on the sleep quality of patients with uremic pruritus undergoing hemodialysis: a randomized crossover study. 2021;18(1):217 [Crossref]
10- Naseri-Salahshour V, Sajadi M, Nikbakht-Nasrabadi A, Davodabady F, Fournier A. The effect of nutritional education program on quality of life and serum electrolytes levels in hemodialysis patients: A single-blind randomized controlled trial. Patient Education and Counseling. 2020;103(9):1774 [Crossref]
11- Chen H, Tang H, Lu C, Chien C. Warning signs and severe dengue in end stage renal disease dialysis patients. Journal of Microbiology, Immunology and Infection. 2020;53(6):979 [Crossref]
12- Mehrpooya M, Gholyaf M, Yasrebifar F, Mohammadi Y, Sheikh V.

Evaluation of Efficacy of Mirtazapine on Pruritus and Serum Histamine and Serotonin Levels in Patients Undergoing Hemodialysis: A Before–After Pilot Clinical Trial

. IJNRD. 2020;Volume 13:129 [Crossref]
13- Cho H, Park S, Kim N, Choi S, Song S, Yoo J, Kim M, Chung J. Effect of anesthetics on postoperative nausea and vomiting after peripheral vascular surgery in end-stage renal disease patients: A retrospective observational study. Front Surg. 2022;9 [Crossref]
14- Gitau K, Howe H, Ginsberg L, Perl J, Ailon J. Therapeutic Cannabis Use in Kidney Disease: A Survey of Canadian Nephrologists. Kidney Medicine. 2022;4(5):100453 [Crossref]
15- Meadowcroft A, Cizman B, Holdstock L, Biswas N, Johnson B, Jones D, Nossuli A, Lepore J, Aarup M, Cobitz A. Daprodustat for anemia: a 24-week, open-label, randomized controlled trial in participants on hemodialysis. 2019;12(1):139 [Crossref]